Clinical Trial Update: Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ Failure [Phase 2]

View source ↗

Summary

Phase 2 trial comparing a prostacyclin infusion to placebo over 72 hours in trauma patients with hemorrhagic shock and multi-organ dysfunction; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock
• Multiple Organ Dysfunction Syndrome

Drugs mentioned

• Prostacyclin infusion (epoprostenol (prostacyclin))

Snippet

Sponsor: Pär Johansson | Conditions: Multi Organ Failure | Phase 2 | Status: COMPLETED